Abstract
Curcumin possesses remarkable chemotherapeutic activity owing to its anti-inflammatory and anti-oxidant properties. Purpose of the research work was to prepare curcumin-loaded nanoparticles of Eudragit E 100 for topical skin applications through a simple, cost-effective method of nanoprecipitation. Resultant formulation will enhance the water solubility, permeability and bioactivity of curcumin. The particle size and morphology were investigated by dynamic light scattering and electron microscopy. The encapsulation efficiency, drug loading, in vitro drug release were determined by UV spectroscopy. In vitro drug release was conducted at acidic and neutral pH. The interaction of drug with polymers was investigated by Fourier-transform infrared spectroscopy. Ex vivo skin penetration study was conducted using vertical Franz diffusion cell to assess the potential of curcumin nanoparticles to cross the stratum corneum. In vivo evaluation was done in mice model. Results illustrated that particles were in nanometers (˂ 120 nm), with narrow size distribution, spherical in shape and with encapsulation efficiency of more than 75%. Drug release demonstrated the acid-responsive behavior of curcumin nanoparticles while ex vivo permeation and in vivo studies show prominent results of the formulation. It can be concluded from the results that curcumin nanoparticles have a potential to be designed successfully in future as a topical dosage form for the treatment of skin cancer. The present research work concludes that Eudragit E100 can fulfill the requirements related to delivery of curcumin for topical use for the local treatment of skin cancer.
Similar content being viewed by others
References
Adusumilli NC, Mordorski B, Nosanchuk J, Friedman JM, Friedman AJ (2021) Curcumin nanoparticles as a photoprotective adjuvant. Exp Dermatol 30(5):705–709
Agarwal R, Katare O, Vyas S (2001) Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol. Int J Pharm 228:43–52
Ahad A, Aqil M, Kohli K, Sultana Y, Mujeeb M (2016) The ameliorated longevity and pharmacokinetics of valsartan released from a gel system of ultradeformable vesicles. Artif Cells Nanomed Biotechnol 44(6):1457–1463
Ahmadi Nasab N, Hassani Kumleh H, Beygzadeh M et al (2018) Delivery of curcumin by a pH-responsive chitosan mesoporous silica nanoparticles for cancer treatment. Artif Cells Nanomed Biotechnol 46:75–81
Alves MP, Scarrone AL, Santos M et al (2017) Human skin penetration and distribution of nimesulide from hydrophilic gels containing nanocarriers. Int J Pharm 341:215–220
Araki K, Yoshizumi M, Kimura S, Tanaka A, Inoue D, Furubayashi T, Sakane T, Enomura M (2020) Application of a microreactor to pharmaceutical manufacturing: preparation of amorphous curcumin nanoparticles and controlling the crystallinity of curcumin nanoparticles by ultrasonic treatment. AAPS PharmSciTech 21(1):17
Chen HY, Fang J-Y (2000) Therapeutic patents for topical and transdermal drug delivery systems. Expert Opin Ther Pat 10(7):1035–1043
Chinembiri TN, Plessis LH, Gerber M et al (2014) Review of natural compounds for potential skin cancer treatment. Molecules 19:11679–11721
Esfandiarpour-Boroujeni S, Bagheri-Khoulenjani S, Mirzadeh H et al (2017) Fabrication and study of curcumin loaded nanoparticles based on folate-chitosan for breast cancer therapy application. Carbohydrate 168:14–21
Fang YP, Huang YB, Wu PC et al (2009) Topical delivery of 5-aminolevulinic acid-encapsulated ethosomes in a hyper proliferative skin animal model using the CLSM technique to evaluate the penetration behavior. Eur J Pharm Biopharm 73:391–398
Ghosh S, Dutta S, Sarkar A, Kundu M, Sil PC (2021) Targeted delivery of curcumin in breast cancer cells via hyaluronic acid modified mesoporous silica nanoparticle to enhance anticancer efficiency. Colloids Surf B Biointerfaces 197:111–404
Govender T, Riley T, Ehtezazi T et al (2000) Defining the drug incorporation properties of PLA–PEG nanoparticles. Int J Pharm 199:95–110
Hamzehzadeh L, Atkin SL, Majeed M et al (2018) The versatile role of curcumin in cancer prevention and treatment: a focus on PI3K/AKT pathway. J Cell Physiol 233:6530–6537
Higuchi T (1963) Mechanism of sustained action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. Int J Pharm 52:1145–1149
Huang PH, Hu SCS, Lee CW et al (2016) Design of acid-responsive polymeric nanoparticles for 7,3′,4′-trihydroxyisoflavone topical administration. Int J Nanomed 11:1615
Hyvönen S, Peltonen L, Karjalainen M et al (2005) Effect of nanoprecipitation on the physicochemical properties of low molecular weight poly (l-lactic acid) nanoparticles loaded with salbutsamol sulphate and beclomethasone dipropionate. Int J Pharm 295:269–281
Ibraheem D, Iqbal DM, Agusti G et al (2015) Effects of process parameters on the colloidal properties of polycaprolactone microparticles prepared by double emulsion like process. Colloid Surf A Physicochem Eng Asp 445:79–91
Jantarat C (2013) Bioavailability enhancement techniques of herbal medicine: a case example of curcumin. Int J Pharm Pharm Sci 5:493–500
Kachuri L, De P, Ellison LF, Semenciw R (2013) Cancer incidence, mortality and survival trends in Canada, 1970–2007. Chronic Dis Inj Can 33(2):55–59
Krishnakumar N, Sulfikkarali N, Rajendra Prasad N et al (2011) Enhanced anticancer activity of naringenin-loaded nanoparticles in human cervical (HeLa) cancer cells. Prev Nutr Food Sci 1:223–231
Kumari M, Sharma N, Manchanda R, Gupta N, Syed A, Bahkali AH, Nimesh S (2021) PGMD/curcumin nanoparticles for the treatment of breast cancer. Sci Rep 1:1–7
Kunnumakkara AB, Anand P, Aggarwal BB (2008) Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett 269:199–225
Kurzrock R, Li L, Mehta K et al (2019) University of Texas system, liposomal curcumin for treatment of cancer. US Patent Appl 16:205–816
Lamprecht A, Ubrich N, Hombreiro Pérez M et al (1999) Biodegradable monodispersed nanoparticles prepared by pressure homogenization-emulsification. Int J Pharm 184:97–105
Lee SC, Oh JT, Jang MH et al (1999) Quantitative analysis of polyvinyl alcohol on the surface of poly (d, l-lactide-co-glycolide) microparticles prepared by solvent evaporation method: effect of particle size and PVA concentration. J Controll Release 59:123–132
Lee SH, Jeong SK, Ahn SK (2006) An update of the defensive barrier function of skin. Yonsei Med J 47:293–306
Liu J, Xu L, Liu C et al (2012) Preparation and characterization of cationic curcumin nanoparticles for improvement of cellular uptake. Carbohyd Polym 90:16–22
Maeda H, Bharate G, Daruwalla J (2009) Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. Eur J Pharm Biopharm 71:409–419
Mangalathillam SR, Ejinold NS, Nair A et al (2012) Curcumin loaded chitin nanogels for skin cancer treatment via the transdermal route. Nanoscale 4:239–250
Markman JL, Rekechenetskiy A, Holler E et al (2016) Nanomedicine therapeutic approaches to overcome cancer drug resistance. Adv Drug Deliv Rev 65:1866–1879
Mirzaei H, Masoudifar A, Sahebkar A et al (2018) MicroRNA: a novel target of curcumin in cancer therapy. J Cell Physiol 233:3004–3015
Mora-Huertas C, Fessi H, Elaissari A (2011) Influence of process and formulation parameters on the formation of submicron particles by solvent displacement and emulsification–diffusion methods: critical comparison. Adv Colloid Interface Sci 163:90–122
Oktay AN, Ilbasmis-Tamer S, Han S, Uludag O, Celebi N (2020) Preparation and in vitro/in vivo evaluation of flurbiprofen nanosuspension-based gel for dermal application. Eur J Pharm Sci 155:105548
Ombredane AS, Silva VR, Andrade LR, Pinheiro WO, Simonelly M, Oliveira JV, Pinheiro AC, Gonçalves GF, Felice GJ, Garcia MP, Campos PM (2021) In vivo efficacy and toxicity of curcumin nanoparticles in breast cancer treatment: a systematic review. Front Oncol 11:612903
Oungbho K, Müller BW (1997) Chitosan sponges as sustained release drug carriers. Int J Pharm 156:229–237
Papadimitriou S, Bikiaris D (2009) Novel self-assembled core–shell nanoparticles based on crystalline amorphous moieties of aliphatic copolyesters for efficient controlled drug release. J Control Release 138:177–184
Patel NA, Patel NJ, Patel RP (2009a) Formulation and evaluation of curcumin gel for topical application. Pharm Dev Technol 14:83–92
Patel RD, Singh S, Navin S et al (2009b) Development and characterization of curcumin loaded transfersome for transdermal delivery. J Pharm Sci Res 2009(1):71–80
Prajakta D, Ratnesh J, Chandan K et al (2009) Curcumin loaded pH-sensitive nanoparticles for the treatment of colon cancer. J Biomed Nanotechnol 2009(5):445–455
Priyadarsini KI (2014) The chemistry of curcumin: from extraction to therapeutic agent. Molecules 19:20091–20112
Rachmawati H, Budiputra DK, Mauludin R (2015) Curcumin nanoemulsion for transdermal application: formulation and evaluation. Drug Dev Ind Pharm 41:560–566
Ramirez CN, Li W, Zhang C et al (2018) In vitro-in vivo dose response of ursolic acid, sulforaphane, PEITC, and curcumin in cancer prevention. AAPS J 20:19
Ritger PL, Peppas NA (1987) A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J Control Release 5:37–42
Sahu P, Kashaw SK, Sau S, Kushwah V, Jain S, Agrawal RK, Iyer AK (2019) pH triggered and charge attracted nanogel for simultaneous evaluation of penetration and toxicity against skin cancer: in-vitro and ex-vivo study. Int J Biol Macromol 128:740–751
Shakeri A, Ward N, Panahi Y et al (2019) Anti-angiogenic activity of curcumin in cancer therapy: a narrative review. Curr Vasc Pharmacol 17:262–269
Simonetti LD, Gelfuso GM, Barbosa JC et al (2009) Assessment of the percutaneous penetration of cisplatin: the effect of monoolein and the drug skin penetration pathway. Eur J Pharm Biopharm 73:90–94
Syng-ai C, Kumari AL, Khar A (2004) Effect of curcumin on normal and tumor cells: role of glutathione and bcl-2. Mol Cancer Ther 3:1101–1108
Tang J, Xu N, Ji H, Liu H et al (2011) Eudragit nanoparticles containing genistein: formulation, development, and bioavailability assessment. Int J Nanomed 2011(6):2429
Taveira SF, Lopez RFV (2011) Topical administration of anticancer drugs for skin cancer treatment, in Skin Cancers-Risk Factors. Prevention and Therapy. InTech
Tomren M, Másson M, Loftsson T, Tønnesen HH (2007) Studies on curcumin and curcuminoids: XXXI. Symmetric and asymmetric curcuminoids: stability, activity and complexation with cyclodextrin. Int J Pharm 338:27–34
Tzeng CW, Yen FL, Wu TH et al (2011) Enhancement of dissolution and antioxidant activity of kaempferol using a nanoparticle engineering process. J Agric Food Chem 2011(59):5073–5080
Wahlang B, Pawar YB, Bansal AK (2011) Identification of permeability-related hurdles in oral delivery of curcumin using the Caco-2 cell model. Eur J Pharm Biopharm 77:275–282
Xie J, Fan Z, Li Y et al (2018) Design of pH-sensitive methotrexate prodrug-targeted curcumin nanoparticles for efficient dual-drug delivery and combination cancer therapy. Int J Nanomed 13:1381
Xu G, Sunada S (1995) Influence of formulation change on drug release kinetics from hydroxypropylmethylcellulose matrix tablets. Chem Pharm Bul 43:483–487
Yadav KS, Sawant KK (2010) Modified nanonanoprecipitation method for preparation of cytarabine-loaded PLGA nanoparticles. AAPS PharmSciTech 11:1456–1465
Yallapu MM, Nagesh PKB, Jaggi M, Chauhan S (2015) Therapeutic applications of curcumin nanoformulations. AAPS J 17(6):1341–1356
Yang YY, Chung TS, Ng NP (2001) Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method. Biomaterials 22:231–241
Yavarpour-Bali H, Ghasemi-Kasman MP, Pirzadeh M (2019) Curcumin-loaded nanoparticles: a novel therapeutic strategy in treatment of central nervous system disorders. Int J Nanomed 2019(14):4449–4460
Zafar S, Beg S, Panda SK, Rahman M, Alharbi KS, Jain GK, Ahmad FJ (2019) Novel therapeutic interventions in cancer treatment using protein and peptide-based targeted smart systems. Seminar Cancer Biol 69:249–267
Zamarioli CM, Martins RM (2015) Nanoparticles containing curcuminoids (Curcuma longa): development of topical delivery formulation. Rev Bras Farmacogn 25:53–60
Acknowledgements
Authors are thankful to Evonik Pakistan for providing Eudragit, the polymer.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Authors declare no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Bibi, N., ur Rehman, A., Rana, N.F. et al. Formulation and characterization of curcumin nanoparticles for skin cancer treatment. Appl Nanosci 12, 3421–3436 (2022). https://doi.org/10.1007/s13204-022-02346-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13204-022-02346-4